Literature DB >> 16730124

Occipital afferent activation of second order neurons in the trigeminocervical complex in rat.

K Le Doaré1, S Akerman, P R Holland, M P Lasalandra, A Bergerot, J D Classey, Y E Knight, P J Goadsby.   

Abstract

Stimulation of the greater occipital nerve produces excitation of second order neurons in the trigeminocervical complex. Given that neck pain is very common in primary headache disorders, this convergent excitation may play a role in pain referral from cervical structures. While previous studies have demonstrated a physiological model for this convergence, this study sought an anatomical approach to examine the distribution of second order neurons in the trigeminocervical complex receiving greater occipital nerve input. In addition, the role of glutamatergic NMDA receptor activation within the trigeminocervical complex in response to cervical afferents was studied. Noxious stimulation of the occipital muscle in rat using mustard oil and mineral oil produced significantly altered Fos expression in the trigeminocervical complex compared with the surgical control (H(4)=31.3, P<0.001, Kruskal-Wallis). Baseline expression was 11 (median, range 4, 17) fos positive cells in the trigeminocervical complex, occipital muscle treated with mustard oil produced 23 (17, 33) and mineral oil a smaller effect of 19 (15, 25) fos positive cells, respectively (P=0.046). The effects of both mustard and mineral oil were reversed by the NMDA-receptor antagonist MK801. This study introduces a model for examining trigeminocervical complex activity after occipital afferent stimulation in the rat that has good anatomical resolution and demonstrates involvement of glutamatergic NMDA receptors at this important synapse.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730124     DOI: 10.1016/j.neulet.2006.04.049

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  [Subcutaneous peripheral stimulation of the greater occipital nerve for the treatment of chronic headache syndromes].

Authors:  V Tronnier; D Rasche
Journal:  Schmerz       Date:  2010-09       Impact factor: 1.107

Review 2.  Glutamate and Its Receptors as Therapeutic Targets for Migraine.

Authors:  Jan Hoffmann; Andrew Charles
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

Review 3.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 4.  Advances in the pathophysiology of tension-type headache: from stress to central sensitization.

Authors:  Yaniv Chen
Journal:  Curr Pain Headache Rep       Date:  2009-12

Review 5.  Peripheral nerve stimulation for neuropathic pain.

Authors:  Konstantin V Slavin
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 6.  Interventional Treatment for Post-traumatic Headache.

Authors:  Francis X Conidi
Journal:  Curr Pain Headache Rep       Date:  2016-06

7.  Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region.

Authors:  B Filipović; I Matak; Z Lacković
Journal:  J Neural Transm (Vienna)       Date:  2013-12-24       Impact factor: 3.575

8.  Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats.

Authors:  Olga A Lyubashina; Sergey S Panteleev; Alexey Y Sokolov
Journal:  J Neural Transm (Vienna)       Date:  2016-09-27       Impact factor: 3.575

9.  Central sensitization induced in trigeminal and upper cervical dorsal horn neurons by noxious stimulation of deep cervical paraspinal tissues in rats with minimal surgical trauma.

Authors:  Howard Vernon; Kaiqi Sun; Yunfeng Zhang; Xian-Min Yu; Barry J Sessle
Journal:  J Manipulative Physiol Ther       Date:  2009-09       Impact factor: 1.437

Review 10.  Migraine as a visceral pain.

Authors:  Pietro Cortelli; Pasquale Montagna
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.